Title : Survival and tolerance to sorafenib in Child-Pugh B patients with hepatocellular carcinoma: a prospective study.

Pub. Date : 2018 Oct

PMID : 29948358






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Survival and tolerance to sorafenib in Child-Pugh B patients with hepatocellular carcinoma: a prospective study. Sorafenib carboxypeptidase B1 Homo sapiens
2 We evaluated the overall survival (OS) and tolerance to sorafenib in a large cohort of Child-Pugh B (CP-B) HCC patients as compared to CP-A HCC patients. Sorafenib carboxypeptidase B1 Homo sapiens
3 This real-life cohort of CP-B HCC patients treated with sorafenib had a higher survival than that described in the literature, with a satisfactory safety profile. Sorafenib carboxypeptidase B1 Homo sapiens
4 Despite the high prevalence of severe AEs in CP-B patients, there were fewer treatment interruptions in this group, indicating that Child-Pugh B patients can tolerate treatment and may benefit from sorafenib. Sorafenib carboxypeptidase B1 Homo sapiens
5 Despite the high prevalence of severe AEs in CP-B patients, there were fewer treatment interruptions in this group, indicating that Child-Pugh B patients can tolerate treatment and may benefit from sorafenib. Sorafenib carboxypeptidase B1 Homo sapiens